Clinical Trial Update: A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the immune response and safety of an investigational chickenpox vaccine in healthy children aged 12 to 15 months, current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chickenpox

Drugs mentioned

• Investigational varicella vaccine (varicella vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Chickenpox | Phase 3 | Status: RECRUITING